Correlation Between Network18 Media and Biofil Chemicals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Network18 Media and Biofil Chemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Network18 Media and Biofil Chemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Network18 Media Investments and Biofil Chemicals Pharmaceuticals, you can compare the effects of market volatilities on Network18 Media and Biofil Chemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Network18 Media with a short position of Biofil Chemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Network18 Media and Biofil Chemicals.

Diversification Opportunities for Network18 Media and Biofil Chemicals

0.93
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Network18 and Biofil is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Network18 Media Investments and Biofil Chemicals Pharmaceutica in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofil Chemicals Pha and Network18 Media is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Network18 Media Investments are associated (or correlated) with Biofil Chemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofil Chemicals Pha has no effect on the direction of Network18 Media i.e., Network18 Media and Biofil Chemicals go up and down completely randomly.

Pair Corralation between Network18 Media and Biofil Chemicals

Assuming the 90 days trading horizon Network18 Media Investments is expected to under-perform the Biofil Chemicals. But the stock apears to be less risky and, when comparing its historical volatility, Network18 Media Investments is 1.17 times less risky than Biofil Chemicals. The stock trades about -0.36 of its potential returns per unit of risk. The Biofil Chemicals Pharmaceuticals is currently generating about -0.12 of returns per unit of risk over similar time horizon. If you would invest  6,281  in Biofil Chemicals Pharmaceuticals on November 29, 2024 and sell it today you would lose (1,284) from holding Biofil Chemicals Pharmaceuticals or give up 20.44% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Network18 Media Investments  vs.  Biofil Chemicals Pharmaceutica

 Performance 
       Timeline  
Network18 Media Inve 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Network18 Media Investments has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in March 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Biofil Chemicals Pha 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Biofil Chemicals Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's technical indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Network18 Media and Biofil Chemicals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Network18 Media and Biofil Chemicals

The main advantage of trading using opposite Network18 Media and Biofil Chemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Network18 Media position performs unexpectedly, Biofil Chemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofil Chemicals will offset losses from the drop in Biofil Chemicals' long position.
The idea behind Network18 Media Investments and Biofil Chemicals Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation